AIFM1 Human

Apoptosis-Inducing Factor, Mitochondrion-Associated, 1 Human Recombinant
Cat. No.
BT23239
Source
Escherichia Coli.
Synonyms
Apoptosis-inducing factor 1, mitochondrial, Programmed cell death protein 8, AIFM1, AIF, PDCD8, CMTX4, COWCK, COXPD6, isoform 2 precursor, Apoptosis-Inducing Factor, Mitochondrion-Associated, 1.
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 95.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

AIFM1 Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 537 amino acids (98-609) and having a molecular mass of 58.5 kDa.
AIFM1 is fused to a 25 amino acid His-Tag at N-terminus and purified by proprietary chromatographic techniques.

Product Specs

Introduction
Apoptosis-Inducing Factor, Mitochondrion-Associated, 1 (AIFM1), also known as AIF, is a mitochondrial flavoprotein that plays a crucial role in programmed cell death (apoptosis). Upon apoptosis induction, AIFM1 is released from the mitochondria and translocates to the nucleus. In the nucleus, it contributes to DNA fragmentation and chromatin condensation, characteristic features of apoptosis. AIFM1 also participates in the release of cytochrome c and caspase-9 from mitochondria, further amplifying the apoptotic cascade. Notably, while overexpression of the anti-apoptotic protein Bcl-2 can prevent AIFM1 release from mitochondria, it does not block AIFM1's ability to induce apoptosis once it is released.
Description
This product consists of the recombinant human AIFM1 protein, produced in E. coli. The protein is a single, non-glycosylated polypeptide chain that encompasses amino acids 98 to 609 of the full AIFM1 sequence, resulting in a molecular weight of 58.5 kDa. For purification and manipulation purposes, the recombinant protein includes a 25 amino acid His-Tag fused to its N-terminus. The purification process involves proprietary chromatographic techniques to ensure high purity.
Physical Appearance
The product is supplied as a sterile, colorless solution.
Formulation
The AIFM1 protein is provided at a concentration of 0.5 mg/ml in a buffer solution containing 20mM Tris-HCl (pH 8.0), 0.1M NaCl, and 10% glycerol.
Stability
For short-term storage (up to 2-4 weeks), the product can be stored at 4°C. For long-term storage, it is recommended to store the product at -20°C. To further enhance stability during long-term storage, consider adding a carrier protein such as HSA or BSA to a final concentration of 0.1%. It is important to avoid repeated freeze-thaw cycles to maintain protein integrity.
Purity
The purity of the AIFM1 protein is greater than 95%, as determined by SDS-PAGE analysis.
Synonyms
Apoptosis-inducing factor 1, mitochondrial, Programmed cell death protein 8, AIFM1, AIF, PDCD8, CMTX4, COWCK, COXPD6, isoform 2 precursor, Apoptosis-Inducing Factor, Mitochondrion-Associated, 1.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSEFLGLTP EQKQKKAALS ASEGEEVPQD KAPSHVPFLL IGGGTAAFAA ARSIRARDPG ARVLIVSEDP ELPYMRPPLS KELWFSDDPN VTKTLRFKQW NGKERSIYFQ PPSFYVSAQD LPHIENGGVA VLTGKKVVQL DVRDNMVKLN DGSQITYEKC LIATGGTPRS LSAIDRAGAE VKSRTTLFRK IGDFRSLEKI SREVKSITII GGGFLGSELA CALGRKARAL GTEVIQLFPE KGNMGKILPE YLSNWTMEKV RREGVKVMPN AIVQSVGVSS GKLLIKLKDG RKVETDHIVA AVGLEPNVEL AKTGGLEIDS DFGGFRVNAE LQARSNIWVA GDAACFYDIK LGRRRVEHHD HAVVSGRLAG ENMTGAAKPY WHQSMFWSDL GPDVGYEAIG LVDSSLPTVG VFAKATAQDN PKSATEQSGT GIRSESETES EASEITIPPS TPAVPQAPVQ GEDYGKGVIF YLRDKVVVGI VLWNIFNRMP IARKIIKDGE QHEDLNEVAK LFNIHED.

Product Science Overview

Introduction

Apoptosis-Inducing Factor, Mitochondrion-Associated, 1 (AIFM1) is a crucial protein involved in the regulation of apoptosis, a form of programmed cell death. This protein is encoded by the AIFM1 gene located on the X chromosome in humans . AIFM1 plays a significant role in both the mitochondrial respiratory chain and the induction of caspase-independent apoptosis .

Discovery and Historical Background

AIFM1 was first described in 1999 as the first caspase-independent apoptotic inducer . It was identified as a protein that could provoke programmed cell death (PCD) after being released from the mitochondria . This discovery highlighted the central role of mitochondria in both cellular redox metabolism and the induction of PCD .

Structure and Localization

The AIFM1 protein is synthesized in the cytosol as a precursor containing 613 amino acids . It includes an N-terminal mitochondrial localization signal (MLS) that directs the protein to the mitochondrial intermembrane space (IMS) . Upon entering the IMS, the N-terminal segment is cleaved, resulting in the mature mitochondrial form of AIFM1 . This mature form anchors to the inner mitochondrial membrane and incorporates the flavin adenine dinucleotide (FAD) cofactor .

Function and Mechanism

In healthy cells, AIFM1 resides in the mitochondrial intermembrane space, where it plays a vital role in redox metabolism . Upon receiving apoptotic stimuli, AIFM1 is released from the IMS into the cytosol and subsequently translocated into the nucleus . In the nucleus, AIFM1 induces chromatin condensation and large-scale DNA fragmentation, leading to cell death . This process is caspase-independent, distinguishing AIFM1 from other apoptotic factors that rely on caspase activation .

Role in Apoptosis

AIFM1 is a key player in the intrinsic pathway of apoptosis. It triggers chromatin condensation and DNA fragmentation, essential steps in the apoptotic process . The release of AIFM1 from the mitochondria to the cytosol and its subsequent translocation to the nucleus are critical events in the execution of apoptosis . This protein’s ability to induce apoptosis without the involvement of caspases makes it a unique and important factor in cell death regulation .

Clinical Significance

The study of AIFM1 has significant implications for understanding various diseases and conditions where apoptosis plays a crucial role. Dysregulation of apoptosis can lead to conditions such as cancer, neurodegenerative diseases, and immune disorders . Understanding the mechanisms of AIFM1 and its role in apoptosis can provide insights into potential therapeutic targets for these diseases .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.